ijms-logo

Journal Browser

Journal Browser

Novel Biomarkers and Molecular Targets in Gliomas

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 30 July 2024 | Viewed by 96

Special Issue Editors


E-Mail Website
Guest Editor
Neurosurgery Division of “Spaziani” Hospital, Frosinone, Italy
Interests: glioblastoma ultrastructural; morphological biomarkers; diffuse low-grade gliomas
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Neurosurgery, Sapienza University of Rome, 00135 Roma, Italy
Interests: neuro-oncology; lipid vesicles; microglia; neurosurgery; ATRX; EGFR

Special Issue Information

Dear Colleagues,

The molecular aspect influences the modern classification and treatment strategies for gliomas. It is the constant fascinating research that opens new therapeutic and diagnostic possibilities. This Special Issue aims to highlight the efforts of researchers in identifying and characterizing new molecular markers in order to guide increasingly effective diagnostic and therapeutic strategies in the fight against gliomas.

Therefore, it is our pleasure to invite investigators to contribute original research articles as well as review to this Special Issue that is aimed at promoting the diffusion of the current knowledge of the molecular basis of neuro-oncology. We are particularly interested in articles that provide new insights into pathophysiological mechanisms, which could be used to achieve original diagnostic and therapeutic approaches.

Potential topics include, but are not limited to, the following:

  • Molecular insights into glioblastoma and the intrinsic brain tumor pathogenesis;
  • The clinical and surgical translations of the latest pathophysiological findings;
  • Molecular prognostic factors in glioblastoma and intrinsic brain tumors;
  • Nutraceuticals and brain tumors;
  • Autophagy related to the biology of gliomas;
  • Micro-RNA in the pathogenesis of glial brain tumors;
  • Cytoskeletal proteins as glioblastoma;
  • The ultrastructural biomarkers of glial brain tumors;
  • Molecular targeted therapy for gliomas;
  • Gene therapy for gliomas.

Dr. Placido Bruzzaniti
Dr. Pietro Familiari
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • EVs
  • Ki67
  • biomarker
  • glioblastoma
  • lipid vesicles
  • microglia
  • ATRX
  • EGFR
  • IDH1
  • MGMT
  • 1p/19q codeletion

Published Papers

This special issue is now open for submission.
Back to TopTop